Has Leonard Krilov received payments from drug or device companies?

Yes. Drug and device makers reported $63,649 in general payments to Leonard Krilov across 77 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Leonard Krilov did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Leonard Krilov come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Leonard Krilov

Pediatric Infectious Diseases · Mineola, NYNPI 1760403927

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.0%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Sanofi Pasteur Inc. at 49.6% of the total. Among pediatric infectious diseases clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$63,649in general payments, 2019–2025

Across 77 payments — averaging $826.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi Pasteur Inc.$32K
Pfizer$12K
Merck$11K
Sobi, Inc$5K
AstraZeneca$3K
GSK$1K
plus $49 from 2 others

$515,933in research payments, 2019–2025

Across 122 payments — averaging $4228.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Pfizer$299K
AstraZeneca$79K
Astrazeneca UK Limited$70K
Merck$64K
Sanofi Pasteur Inc.$4K

What the payments were for

Consulting fees$32,45551%
Speaking & faculty fees$20,74233%
Travel & lodging$8,49313%
Food & beverage$1,9593%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi Pasteur Inc.	36	$31,542
Pfizer(2 entities)	7	$11,664
Merck	14	$10,948
Sobi, Inc	11	$4,858
AstraZeneca	5	$3,268
GSK	2	$1,321
Melinta Therapeutics, LLC	1	$30
Verrica Pharmaceuticals Inc.	1	$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$63,649 in reported general payments places this provider in the 90th percentile of 73 pediatric infectious diseases providers in New York.

See all pediatric infectious diseases providers in New York →

Other pediatric infectious diseases in Mineola

Asif NoorMineola$1K
Joseph DomachowskeSyracuse$470K
Jana ShawWatertown$346K
Philip LarussaNew York$125K
Lisa SaimanNew York$73K
Brenda TesiniRochester$45K
Margaret HammerschlagBrooklyn$33K
Sallie PermarNew York City$18K
Betsy HeroldNew York$12K
John ZahradnikGoshen$10K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →